TEMPEST THERAPEUTICS
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor immunity pathways. The company has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct pathways relevant to mounting an effective anti-tumor response. Tempest Therapeutics was established in 2011 and is headquartered in San Francisco, California.
TEMPEST THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.tempesttx.com
Total Employee:
1+
Status:
Active
Contact:
(415) 798-8589
Email Addresses:
[email protected]
Total Funding:
90 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag Microsoft Exchange Online
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-29 | Millendo Therapeutics | Millendo Therapeutics acquired by Tempest Therapeutics | N/A |
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Tempest Therapeutics
Versant Ventures
Versant Ventures investment in Post-IPO Equity - Tempest Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Tempest Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Tempest Therapeutics
Quan Capital
Quan Capital investment in Series B - Tempest Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Tempest Therapeutics
Versant Ventures
Versant Ventures investment in Series B - Tempest Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Tempest Therapeutics
Official Site Inspections
http://www.tempesttx.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.93 K
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Tempest Therapeutics"
Leadership | Tempest Therapeutics
Mr. Mullins joined Tempest as vice president, regulatory affairs in September 2024, bringing over 25 years of regulatory affairs expertise ranging from pre-IND to licensing application …See details»
TempestTx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore TempestTx, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Disease Domain:Neoplasms, Technology Platform:Small molecule drug, Drug:TPST …See details»
Tempest Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Jan 23, 2025 More information about Tempest can be found on the company’s website at www.tempesttx.com. Forward-Looking Statements This press release contains forward …See details»
Investor Relations | Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and …See details»
ir.tempesttx.com
Tempest Reports Third Quarter 2024 Financial Results and …
Nov 12, 2024 More information about Tempest can be found on the company’s website at www.tempesttx.com. Forward-Looking Statements This press release contains forward …See details»
Orphanet: Tempest Therapeutics
Phone 1: [email protected] Institution's website Contacts. Professionals: other TEMPEST THERAPEUTICS Additional information. Activities of this institution. Orphan designation(s) …See details»
Join Our Team | Tempest Therapeutics
The people at Tempest have come together to discover and develop novel therapeutics to treat cancer – a challenging goal, but worth it. Although it’s nice to have, hope isn’t a strategy for success, so we seek colleagues across all …See details»
Tempest Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Tempest Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 12 clinical trials, 62 news.See details»
Press Release | Tempest Therapeutics
October 21, 2020. Sam Whiting, M.D., Ph.D., Joins Tempest as Executive Vice President and Chief Medical Officer. South San Francisco, CA – October 21, 2020 - Tempest Therapeutics, …See details»
FDA Study May Proceed Notice Received for Phase 2 Trial of TPST …
Information about Tempest can be found on the company s website at www.tempesttx.com . Forward-Looking Statements This press release contains forward-looking statements …See details»
Engine – – Cancer immunology programs launched from Versant’s …
3/14/2019 Press Release https://www.tempesttx.com/news/032818/ 1/ 3 MARCH 28, 2018 TEMPEST THERAPEUTICS CLOSES $70 MILLION SERIES B FINANCING – Cancer …See details»
Press Release | Tempest Therapeutics
Jun 22, 2020 Tempest is headquartered in South San Francisco and supported by notable healthcare investors. More information about Tempest can be found on the company’s website …See details»
Tempest Therapeutics - Golden
Tempest Therapeutics is a small Molecules for Immuno-Oncology. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Tempest to Present at the H.C. Wainwright 25th Annual Global …
Sep 5, 2023 The company presentation will be available for on-demand viewing Monday, September 11, 2023, at 7:00 a.m. ET on the investor section of the Tempest website at …See details»
Press Release | Tempest Therapeutics
Mar 3, 2021 Oral delivery of a TREX-1 small molecule inhibitor is intended to selectively activate STING in tumors, leading to anti-tumor immunity. Tempest is headquartered in South San …See details»
Tempest Therapeutics Inc - WhaleWisdom.com
Tempesttx.com: 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005 415-798-8589 Formally known as: OVASCIENCE INC COM (DE) Stock Split History Date Ratio; 2018 …See details»
News Release Details - Tempest Therapeutics
Sep 20, 2021 More information about Tempest can be found on the company’s website at www.tempesttx.com. Forward-Looking Statements This press release contains forward …See details»
3’ repair exonuclease 1 (TREX1) inhibitors - tempesttx.com
SITC 38th Annual Meeting, November 1-5, 2023, San Diego, CA [This presentation is the intellectual property of the author/presenter. Contact [email protected] for permission to …See details»
Inhibition of Fatty Acid Oxidation by the Peroxisome Proliferator ...
Society for Immunotherapy of Cancer (SITC) 2024 Spring Scientific Meeting, March 10- 12, 2024, Miami, FL [This presentation is the intellectual property of the author/presenter. Contact …See details»